Summit Global Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,434
Closed -$429K 515
2025
Q4
$429K Buy
8,434
+1,319
+19% +$67.4K 0.03% 356
2025
Q3
$395K Buy
7,115
+4,022
+130% +$235K 0.02% 348
2025
Q2
$213K Sell
3,093
-5,194
-63% -$353K 0.01% 442
2025
Q1
$575K Sell
8,287
-1,226
-13% -$101K 0.04% 269
2024
Q4
$818K Sell
9,513
-26,771
-74% -$2.89M 0.05% 255
2024
Q3
$4.32M Sell
36,284
-16,843
-32% -$2.25M 0.28% 74
2024
Q2
$7.58M Buy
53,127
+25,328
+91% +$3.36M 0.51% 42
2024
Q1
$3.57M Buy
27,799
+3,489
+14% +$415K 0.27% 82
2023
Q4
$2.52M Sell
24,310
-6,927
-22% -$685K 0.16% 110
2023
Q3
$2.84M Sell
31,237
-4,097
-12% -$361K 0.19% 104
2023
Q2
$2.86M Buy
35,334
+110
+0.3% +$8.99K 0.19% 113
2023
Q1
$2.8M Buy
35,224
+4,802
+16% +$341K 0.22% 109
2022
Q4
$2.06M Sell
30,422
-31,064
-51% -$1.82M 0.17% 133
2022
Q3
$3.06M Buy
61,486
+9,884
+19% +$529K 0.28% 101
2022
Q2
$2.88M Sell
51,602
-12,216
-19% -$678K 0.25% 94
2022
Q1
$3.54M Buy
63,818
+3,274
+5% +$168K 0.26% 99
2021
Q4
$3.39M Buy
60,544
+4,004
+7% +$217K 0.22% 97
2021
Q3
$2.71M Sell
56,540
-704
-1% -$34K 0.2% 99
2021
Q2
$2.4M Sell
57,244
-3,238
-5% -$126K 0.14% 116
2021
Q1
$2.04M Buy
60,482
+6,260
+12% +$223K 0.13% 126
2020
Q4
$1.89M Buy
54,222
+12,610
+30% +$436K 0.19% 97
2020
Q3
$1.45M Buy
41,612
+12,038
+41% +$401K 0.15% 103
2020
Q2
$968K Buy
29,574
+6,270
+27% +$200K 0.11% 118
2020
Q1
$701K Sell
23,304
-6,706
-22% -$200K 0.1% 124
2019
Q4
$868K Buy
30,010
+1,300
+5% +$36K 0.09% 179
2019
Q3
$742K Buy
28,710
+570
+2% +$14.4K 0.09% 225
2019
Q2
$718K Buy
28,140
+3,160
+13% +$78.1K 0.09% 185
2019
Q1
$653K Sell
24,980
-10,474
-30% -$257K 0.08% 217
2018
Q4
$817K Buy
35,454
+4
+0% +$89 0.13% 114
2018
Q3
$836K Buy
35,450
+6,170
+21% +$151K 0.11% 155
2018
Q2
$675K Hold
29,280
0.1% 165
2018
Q1
$721K Buy
+29,280
New +$769K 0.11% 109

Other funds holding NVO